Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed strength.

Biotech stocks set for a rebound in 2024, analysts say Investors warm up to sector amid stabilizing rates and an uptick in dealmaking Last Updated: Dec. 23, 2023 at 6:50 a.m. ET First Published ...

Meanwhile, if you buy the shares while they're down, you will have gotten in on the stock for a bargain -- and can maximize ...

Biotechnology is certainly on the list, if not at the top, of high-growth industries in dire need of a rebound. Following enthusiasm for COVID-19 vaccines in late 2020 and part of 2021 ...

While the stock’s fallen over the last five years, it’s seen a rebound in 2023, posting a 33% gain. ... This is definitely one of the biotech stocks to watch.

Biotech Roundup: 3 Stocks to Watch. Checking in with REGN, INCY, ... REGN) stock is finally on the rebound, after a long-term pullback from its Aug. 27, record high of $1,211.20.

Our Methodology. We used the Finviz stock screener to compile a list of 40 biotech stocks. We then selected the top 12 stocks with the highest analyst upside potential as of January 15, 2025.

July 28, 2022 - Investors are still feeling the burn from biotech's flameout. And with rising interest rates and increasingly strict regulatory scrutiny, it's no wonder they remain wary of being ...

Biotech Stocks Screaming a Buy 10. Incyte Corporation (NASDAQ:INCY) Year to Date Gain as of June 18: 1.87%. Number of Hedge Fund Holders as of Q1: 37.

Biotech stocks have been hit by 'DOGE' and other fears. Why they're a great value now. Provided by Dow Jones Mar 27, 2025, 5:11:00 PM. By Michael Brush .

Picking the right biotech stocks means the difference between treading water and impressive outperformance. To help you achieve the latter for your portfolio, Forbes Advisor has identified nine of ...